Transcription of The Future of Clinical Chemistry and Laboratory Medicine ...
{{id}} {{{paragraph}}}
The Future of Clinical Chemistry and Laboratory Medicine , The diagnostics industry View Peng Yin, , , Director, Global Scientific Affairs Abbott Diagnostic Division (ADD). Agenda Lack of perceived value of Laboratory Medicine Informactics: A solution for addressing Laboratory and health system challenges Immunoassay diagnostics is still a main and fast growing segment in diagnostics Molecular diagnostics : companion diagnostics play a key part of personalized Medicine Point-of-Care (POC). IVD market in emerging nations Central Role of Laboratory Medicine 70%. OF Clinical DECISIONS. ARE INFORMED BY DATA. FROM Laboratory . Medicine . 4%. SPEND. As Is : Healthcare industry High 5. Relative Offering Level 4. 3. 2. 1. Low 0. Price/Cost Quality Clinical Career Public Government of Life Outcome Attractiveness Perception Perception Pharma Nursing Pathology Clinical Specialist Reimbursement Reduction Trend for IVD in Japan $ Billion.
The Future of Clinical Chemistry and Laboratory Medicine, The Diagnostics Industry View Peng Yin, M.D., Ph.D., Director, Global Scientific Affairs
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}